Zuellig Pharma and Organon partner to expand women's health solutions in Myanmar, focusing on reproductive health access and education.
This partnership is crucial for improving reproductive health outcomes in Myanmar, a region where access to such services can be limited. By combining Organon's product portfolio with Zuellig Pharma's distribution network and local market understanding, the initiative aims to empower women with better choices and healthcare, contributing to overall public health improvements.
Partnership with Organon for women's health in Myanmar.
Focus on access to reproductive health products and education.
Aims to address unintended pregnancies and improve health outcomes.
This initiative directly addresses critical women's health needs in Myanmar, a Southeast Asian nation, by improving access to reproductive health products and education.
Focus on access to reproductive health products and education.
Aims to address unintended pregnancies and improve health outcomes.
Sign in to save notes on signals.
Sign In